Estimation of Final Size of COVID-19 Epidemic in Balochistan Province, Pakistan

Final Size of COVID-19 Epidemic in Balochistan

Authors

  • Muhammad Arif Field Epidemiology and Laboratory Training Program, National Institute of Health, Islamabad, Pakistan
  • Aftab Kakar Field Epidemiology and Laboratory Training Program, National Institute of Health, Islamabad, Pakistan
  • Ehsan Larik Field Epidemiology and Laboratory Training Program, National Institute of Health, Islamabad, Pakistan

DOI:

https://doi.org/10.37978/tijfs.v4i2.245

Keywords:

COVID-19, Estimation, Prediction, Prediction model, SIR Model

Abstract

COVID-19 is a new disease that is spreading very fast in Pakistan. Cases have been reported from all of the provinces including Balochistan. The first two confirmed cases in Pakistan had travel history by road from Iran to Balochistan, hence SIR model used to predict the magnitude of the disease in Balochistan from May 2020 on wards when lock down and other social distancing measures were loosen up by the government of Balochistan. Our Prediction model shows that about 30,00000 individuals in Balochistan will be infected by 5th of July 2020. Over all 25% of the total population of Balochistan will be affected by this disease with 98% (2940,000 ) recovery rate by the end of 15th July 2020.

Downloads

Download data is not yet available.

References

Hethcote HW. Mathematics of infectious diseases.SIAM Review. 2000;42(4):599-653. doi:10.1137/S0036144500371907

Wu JT, Leung K, Bushman M, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine. March 2020:1-5. doi:10.1038/s41591-020-0822-7.

Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia.New England Journal of Medicine. 2020;382(13). doi:10.1056/nejmoa2001316

Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro surveillance: bulletin Europeensur les maladies transmissibles = European communicable disease bulletin. 2020;25(4). doi:10.2807/1560-7917.ES.2020.25.4.2000058

Liu T, Hu J, Kang M, et al. Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China. bioRxiv. February 2020:2020.01.25.919787. doi:10.1101/2020.01.25.919787

Wang H, Wang Z, Dong Y, et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Cell Discovery. 2020;6(1):1-8. doi:10.1038/s41421-020-0148-0

Read JM, Bridgen. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Intergovernmental Panel on Climate Change, ed. Antimicrobial agents and chemotherapy. 2014;58(12):7250-7257. doi:10.1101/2020.01.23.20018549

Wu Z, Jama JM-, 2020 undefined. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese. jamanetwork.com. https://jamanetwork.com/journals/jama/article-abstract/2762130.

Liu Y, Gayle A, AW-S-J of travel, 2020 undefined. The reproductive number of COVID-19 is higher compared to SARS coronavirus. academic.oup.com.

Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. jamanetwork.com. https://jamanetwork.com/journals/jama/article-abstract/2762028.9

Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25(10). doi:10.2807/1560-7917.es.2020.25.10.2000180

Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. The Lancet Global Health. 2020;8(4):e480. doi:10.1016/S2214-109X(20)30068-1

Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - Journal of the American Medical Association. 2020. doi:10.1001/jama.2020.264

Published

2020-06-26

How to Cite

Arif, M., Kakar, A. ., & Larik, E. . (2020). Estimation of Final Size of COVID-19 Epidemic in Balochistan Province, Pakistan: Final Size of COVID-19 Epidemic in Balochistan. The International Journal of Frontier Sciences, 4(2). https://doi.org/10.37978/tijfs.v4i2.245